Peptides DB
Research-centric peptide and protocol reference hub
Study 4 of 6CJC-1295 literatureSemanticScholar2010

Semantic Scholar search for CJC-1295

Not reported in abstract.

Read at SemanticScholarAdd to compare

Where it sits

this study against the rest of the cjc-1295 corpus
4
Preclinical · this one
0
Observational
0
Open-label
0
Randomised
2
Reviews

Summary and findings

Not reported in abstract.

How much of this paper we could read: title only (0.00). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2010

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Limitations

  • Not reported in abstract.
  • Not reported in abstract.

Elsewhere in the CJC-1295 corpus

BInjectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications.europepmc · 2026HumanBInjectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications.PubMed · 2026HumanDCationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.PubMed · 2023 · LOD of 0.2 ng/mL.DChromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.PubMed · 2024 · Not reported in abstract.DAnalysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.PubMed · Achieved LODs (≤ 0.5 ng/mL) and LOIs (0.5-0.75 ng/mL).